Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression-Reference-Cited by-同舟云学术

Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression

Published:2020-05 Issue:2 Volume:526 Page:396-403
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Zhang Shu,Long Jian,Hu Yin

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death;Kivela;Br. J. Ophthalmol.,2009

2. Incidence of retinoblastoma in the USA: 1975-2004;Broaddus;Br. J. Ophthalmol.,2009

3. Diagnosis and management of secondary epipapillary retinoblastoma;Fabian;Br. J. Ophthalmol.,2017

4. Disparities in retinoblastoma presentation, treatment, and outcomes in developed and less-developed countries;Singh;Semin. Ophthalmol.,2016

5. Treatment of retinoblastoma in 2015: agreement and disagreement;Abramson;JAMA Ophthalmol.,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction of: LINC00514 drives osteosarcoma progression through sponging microRNA-708 and consequently increases URGCP expression;Aging;2024-08-15

2. Retraction of: Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression;Aging;2024-07-31

3. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma;Current Issues in Molecular Biology;2024-05-27

4. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma;Canadian Journal of Ophthalmology;2024-02

5. HMGB1 in the interplay between autophagy and apoptosis in cancer;Cancer Letters;2024-01